Shinva Medical Instrument(600587) Financial Reports - Data and Analysis

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

Income statement Balance sheet Cash flow

YOY

Do not show

Hide blank lines

(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30

Total operating revenue

15.42% 2.44B -2.11% 9.28B -9.58% 6.65B -18.77% 4.44B

Operating revenue

15.42% 2.44B -2.11% 9.28B -9.58% 6.65B -18.77% 4.44B

Other operating revenue

-- -- 50.87% 210.16M -- -- 13.70% 113.21M

Total operating cost

14.91% 2.22B -2.83% 8.68B -10.72% 6.18B -21.37% 4.03B

Operating cost

14.58% 1.8B -4.94% 6.83B -12.37% 4.93B -22.98% 3.27B

Operating tax surcharges

-4.44% 14.66M -1.74% 67.62M -15.28% 46.31M -25.36% 29.59M

Operating expense

12.67% 206.36M -1.60% 887.47M -17.91% 590.2M -24.90% 380.55M

Administration expense

19.74% 113.53M 9.37% 461.35M 11.38% 339.41M 3.68% 199.74M

Financial expense

-20.16% 8.36M -42.45% 36.63M -16.25% 37.52M -36.93% 21.51M

-Interest expense (Financial expense)

-10.07% 14.13M -25.35% 56.93M -15.12% 42.78M -21.07% 29.43M

-Interest Income (Financial expense)

-15.18% -4.42M -181.75% -12.03M -10.03% -8.68M -72.20% -6.28M

Research and development

35.57% 73.56M 35.58% 401.27M 34.98% 242.54M 23.57% 124.46M

Credit Impairment Loss

-269.82% -5.29M 35.25% -28.16M 96.87% -1.53M 137.09% 2.24M

Asset Impairment Loss

-60.13% -3.79M -147.20% -51.85M -105.38% -21.11M -189.02% -11.03M

Other net revenue

529.14% 22.39M -107.99% -13.81M -54.15% 51.38M -94.64% 4.7M

Fair value change income

186.93% 18.32M -170.93% -43.36M -162.59% -22.05M -241.76% -34.09M

Invest income

-14.22% 11.03M -55.69% 49.73M -27.18% 81.19M -15.75% 38M

-Including: Investment income associates

0.86% 11.81M 207.02% 62.1M 249.97% 80.99M 169.04% 37.79M

Asset deal income

-326.52% -57.62K -28.82% 2.51M 137.86% 734.88K -24.76% 734.88K

Other revenue

-2.35% 2.18M -5.18% 57.31M -46.67% 14.15M -20.59% 8.84M

Operating profit

36.87% 245.28M -18.66% 585.83M -4.21% 520.34M -3.05% 409.94M

Add:Non operating Income

-12.59% 1.07M 70.93% 11.68M 65.75% 4.89M 47.86% 2.63M

Less:Non operating expense

249.71% 10.24M 138.24% 21.42M 48.58% 8.31M 78.87% 6.67M

Total profit

33.01% 236.11M -19.77% 576.09M -4.37% 516.91M -3.56% 405.9M

Less:Income tax cost

-28.61% 34.08M -71.06% 46.89M -19.51% 87.07M -7.86% 75.36M

Net profit

55.68% 202.03M -4.82% 529.21M -0.59% 429.85M -2.53% 330.54M

Net profit from continuing operation

55.68% 202.03M -4.82% 529.21M 13.18% 429.85M 6.02% 330.54M

Less:Minority Profit

153.80% 5.52M 5,758.20% 26.6M 279.03% 9.91M -16.08% 8.24M

Net profit of parent company owners

54.01% 196.51M -9.68% 502.61M -4.11% 419.93M -2.12% 322.31M

Earning per share

Basic earning per share

48.39% 0.46 -10.22% 1.23 -4.63% 1.03 -2.47% 0.79

Diluted earning per share

48.39% 0.46 -10.22% 1.23 -4.63% 1.03 -3.70% 0.78

Other composite income

57.28% 27.89M 1,022.88% 9.08M 1,407.04% 9.08M

Other composite income of parent company owners

-- -- 57.22% 27.72M 954.25% 8.87M 1,228.76% 8.87M

Other composite income of minority owners

-- -- 67.07% 169.26K 284.87% 209.68K 130.15% 209.68K

Add:Adjusted items effecting composite income

-- -- -- -- -- -- -- 0.01

Total composite income

54.76% 202.03M -2.90% 557.1M 1.75% 438.92M 0.36% 339.62M

Total composite income of parent company owners

53.20% 196.51M -7.63% 530.33M -1.85% 428.8M 0.81% 331.17M

Total composite income of minority owners

142.88% 5.52M 7,358.27% 26.77M 284.63% 10.12M -14.73% 8.44M

Currency Unit

CNYCNYCNYCNY

Accounting Standards

CAS (2007)CAS (2007)CAS (2007)CAS (2007)

Audit Opinions

--Unqualified opinion----

Auditor

--Tianzhu International Accounting Firm (Special General Partnership)----

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Production and sale of medical equipment and devices; production and sales of disinfectants and disinfectants; manufacture of sanitary materials and pharmaceutical products; production and sales of pharmaceutical equipment; application software development and operation; manufacture of optical instruments; manufacture and sale of special environmental protection equipment; production of instruments and supporting software; design, construction, decoration and decoration of laboratory animal equipment, laboratory instruments and air purifiers; production and sales of laboratory animal equipment, laboratory instruments, and air purifiers; medical and pharmaceutical equipment installation and intelligent construction of buildings; equipment leasing; medical and medical treatment of teaching equipment; medical and medical treatment of teaching equipment Equipment specialty retail; special packaging equipment manufacturing; gas and liquid separation and purification equipment manufacturing; gas compression machinery manufacturing; terminal metering equipment manufacturing; cultural and office equipment manufacturing; stationery manufacturing; plastic products manufacturing; household chemical products manufacturing (excluding hazardous chemicals); paper products manufacturing; household textile products manufacturing; after-sales service; technical services; import and export trade; modification, sales and leasing of special structure vehicles; cosmetics wholesale, retail; technical consulting. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments.) The specific scope of business is subject to approval by the Shandong Provincial Market Supervision Administration.

CEO： --

Market： --

Listing Date： 09/27/2002

Futu Hot List

CNHKUS

SearchNews

SymbolLatest price%Chg

Watchlist